GE Healthcare Technologies Inc. on Thursday topped analysts’ expectations for adjusted profit as its business benefited from growth in its ultrasound imaging products and diagnostic drug products.

On an adjusted basis, GE HealthCare earned $1.45 per share, compared with estimates of $1.26 per share. The company's imaging devices unit is the largest among its four segments. Its other three ...

GE HealthCare is leaning heavily into artificial ... Last year, the company closed two acquisitions in the space. It purchased imaging analytics and digital workflow solution company MIM Software ...

Over the last two years, GE HealthCare has been focused on transitioning from solely an imaging company to a health care solutions provider, helping customers solve various challenges. Much of the ...

GE HealthCare ... The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health ...

Shares of GE HealthCare (NASDAQ:GEHC) jumped 9% Thursday after the company issued its Q4 earnings report and 2025 forecast. For Q4, the company posted non-GAAP EPS of $1.45 on revenue of $5.32B.

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which ...